Literature DB >> 19465689

The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding.

Elisabetta Trifiro1, Shirley A Williams, Yann Cheli, Kenichi Furihata, Fabio M Pulcinelli, Diane J Nugent, Thomas J Kunicki.   

Abstract

The 2 most common haplotypes of human GP6, GP6a and GP6b, generate the allelic isoforms glycoprotein VI (GPVI)a and GPVIb that differ by 5 amino acids: S219P, K237E, and T249A in the ectodomains, and Q317L and H322N in the cytoplasmic domain. By quantitative Western blot, we found no association between GP6 genotype and total platelet GPVI content among 132 normal subjects. When expressed as soluble products or as membrane-associated receptors, GPVIa and GPVIb have identical affinities for type I collagen, collagen-related peptide, or convulxin. However, the cytoplasmic domain substitutions in GPVIb have a significant effect on GPVI-dependent subcellular associations and ligand-induced signal transduction. L317 increases binding to calmodulin, whereas N322 attenuates binding to Fyn/Lyn. Consistent with the latter finding, convulxin-induced Syk phosphorylation is significantly attenuated in Dami cells stably transfected with GPVIb, relative to GPVIa. This represents direct evidence that haplotype-related GPVI functional differences are inherent in the cytoplasmic domain substitutions, whereby GPVIb binds less strongly to Fyn/Lyn and attenuates the rate and extent of Syk phosphorylation. These allelic differences in GP6a and GP6b explain functional differences in the respective isoforms, but the molecular basis for the several-fold range in GPVI levels of human platelets remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465689      PMCID: PMC2738573          DOI: 10.1182/blood-2009-03-209510

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Fc Rgamma -independent signaling by the platelet collagen receptor glycoprotein VI.

Authors:  Darren Locke; Changdong Liu; Xiaohui Peng; Hong Chen; Mark L Kahn
Journal:  J Biol Chem       Date:  2003-02-19       Impact factor: 5.157

3.  The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression.

Authors:  Lotta Joutsi-Korhonen; Peter A Smethurst; Angela Rankin; Elaine Gray; Martin IJsseldijk; Catherine M Onley; Nicholas A Watkins; Lorna M Williamson; Alison H Goodall; Philip G de Groot; Richard W Farndale; Willem H Ouwehand
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

Review 4.  The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen.

Authors:  S P Watson; N Asazuma; B Atkinson; O Berlanga; D Best; R Bobe; G Jarvis; S Marshall; D Snell; M Stafford; D Tulasne; J Wilde; P Wonerow; J Frampton
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

5.  Characterization of human glycoprotein VI gene 5' regulatory and promoter regions.

Authors:  Kenichi Furihata; Thomas J Kunicki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

6.  Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI.

Authors:  Robert K Andrews; Katsue Suzuki-Inoue; Yang Shen; David Tulasne; Stephen P Watson; Michael C Berndt
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

7.  Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling.

Authors:  Katsue Suzuki-Inoue; David Tulasne; Yang Shen; Teresa Bori-Sanz; Osamu Inoue; Stephanie M Jung; Masaaki Moroi; Robert K Andrews; Michael C Berndt; Steve P Watson
Journal:  J Biol Chem       Date:  2002-04-09       Impact factor: 5.157

8.  Variation in human platelet glycoprotein VI content modulates glycoprotein VI-specific prothrombinase activity.

Authors:  K Furihata; K J Clemetson; H Deguchi; T J Kunicki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

9.  The Fc receptor gamma-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin.

Authors:  Oscar Berlanga; David Tulasne; Teresa Bori; Daniel C Snell; Yoshiki Miura; Stephanie Jung; Masaaki Moroi; Jonathan Frampton; Steve P Watson
Journal:  Eur J Biochem       Date:  2002-06

10.  Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice.

Authors:  B Nieswandt; V Schulte; W Bergmeier; R Mokhtari-Nejad; K Rackebrandt; J P Cazenave; P Ohlmann; C Gachet; H Zirngibl
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

View more
  9 in total

Review 1.  The genetics of normal platelet reactivity.

Authors:  Thomas J Kunicki; Diane J Nugent
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

Review 2.  Genetic sequence analysis of inherited bleeding diseases.

Authors:  Flora Peyvandi; Tom Kunicki; David Lillicrap
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

Review 3.  The genetics of common variation affecting platelet development, function and pharmaceutical targeting.

Authors:  A D Johnson
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

4.  Platelet Function Changes during Neonatal Cardiopulmonary Bypass Surgery: Mechanistic Basis and Lack of Correlation with Excessive Bleeding.

Authors:  Nicole M J Zwifelhofer; Rachel S Bercovitz; Regina Cole; Ke Yan; Pippa M Simpson; Alyssa Moroi; Peter J Newman; Robert A Niebler; John P Scott; Eckehard A D Stuth; Ronald K Woods; D Woodrow Benson; Debra K Newman
Journal:  Thromb Haemost       Date:  2019-11-21       Impact factor: 5.249

5.  Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists.

Authors:  Andrew D Johnson; Lisa R Yanek; Ming-Huei Chen; Nauder Faraday; Martin G Larson; Geoffrey Tofler; Shiow J Lin; Aldi T Kraja; Michael A Province; Qiong Yang; Diane M Becker; Christopher J O'Donnell; Lewis C Becker
Journal:  Nat Genet       Date:  2010-06-06       Impact factor: 38.330

6.  Heterogeneity of Integrin αIIbβ3 Function in Pediatric Immune Thrombocytopenia Revealed by Continuous Flow Cytometry Analysis.

Authors:  Alexey A Martyanov; Daria S Morozova; Maria A Sorokina; Aleksandra A Filkova; Daria V Fedorova; Selima S Uzueva; Elena V Suntsova; Galina A Novichkova; Pavel A Zharkov; Mikhail A Panteleev; And Anastasia N Sveshnikova
Journal:  Int J Mol Sci       Date:  2020-04-25       Impact factor: 5.923

7.  Polymorphisms in GP6, PEAR1A, MRVI1, PIK3CG, JMJD1C, and SHH Genes in Patients with Unstable Angina.

Authors:  Rafał Rudzik; Violetta Dziedziejko; Monika Ewa Rać; Marek Sawczuk; Agnieszka Maciejewska-Skrendo; Krzysztof Safranow; Andrzej Pawlik
Journal:  Int J Environ Res Public Health       Date:  2020-10-15       Impact factor: 3.390

8.  Conditional knockout of integrin α2β1 in murine megakaryocytes leads to reduced mean platelet volume.

Authors:  David Habart; Yann Cheli; Diane J Nugent; Zaverio M Ruggeri; Thomas J Kunicki
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  Glycoprotein VI Gene Variants Affect Pregnancy Loss in Patients With Platelet Hyperaggregability.

Authors:  Juraj Sokol; Maria Skerenova; Kamil Biringer; Tomas Simurda; Peter Kubisz; Jan Stasko
Journal:  Clin Appl Thromb Hemost       Date:  2018-10-02       Impact factor: 2.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.